Literature DB >> 22715213

Laboratory diagnostics for hepatitis C virus infection.

Saleem Kamili1, Jan Drobeniuc, Aufra C Araujo, Tonya M Hayden.   

Abstract

Identification of prevalent infection by hepatitis C virus (HCV) is based serologically on detecting anti-HCV immunoglobulin G, using immunoassays, immunoblot assays, and, more recently, immunochromatography-based rapid tests. None discriminate between active and resolved HCV infection. Tests for detecting HCV RNA identify active HCV infection but are costly. Serologic assays for HCV antigens have been developed and show potential for diagnosis of active HCV infection, and their performance characteristics are undergoing evaluation. The diagnosis of acute HCV infection without the demonstration of seroconversion remains elusive.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22715213     DOI: 10.1093/cid/cis368

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  40 in total

Review 1.  Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.

Authors:  Natasha Silva Constancio; Maria Lucia Gomes Ferraz; Carmen Tzanno Branco Martins; Angiolina Campos Kraychete; Paulo Lisboa Bitencourt; Marcelo Mazza do Nascimento
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec

2.  A Canadian screening program for hepatitis C: is now the time?

Authors:  Hemant A Shah; Jenny Heathcote; Jordan J Feld
Journal:  CMAJ       Date:  2013-09-30       Impact factor: 8.262

3.  Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection.

Authors:  Guillermina Barril; Juan A Quiroga; María Dolores Arenas; Mario Espinosa; Nuria García-Fernández; Secundino Cigarrán; José A Herrero; Gloria del Peso; Pilar Caro; Rebeca García-Agudo; Yésica Amézquita; Ana Blanco; Pilar Martínez-Rubio; José M Alcázar; Emilio González-Parra; Adoración Martín-Gómez; Inmaculada Castillo; Javier Bartolomé; Vicente Carreño
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

Review 4.  Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients.

Authors:  Akshay Shetty; Adam Buch; Sammy Saab
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

5.  Diagnostic reliability of Architect anti-HCV assay: Experience of a tertiary care hospital in India.

Authors:  Gnanadurai John Fletcher; Anantharam Raghavendran; Jayashree Sivakumar; Prasanna Samuel; Priya Abraham
Journal:  J Clin Lab Anal       Date:  2017-06-28       Impact factor: 2.352

6.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 7.  Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.

Authors:  Filippo Ansaldi; Andrea Orsi; Laura Sticchi; Bianca Bruzzone; Giancarlo Icardi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

8.  Performance evaluation of the mindray anti-HCV assay for the detection of hepatitis C virus infection.

Authors:  Zhi-Hong Yue; Chang-Sheng Xia; Hui Wang
Journal:  J Clin Lab Anal       Date:  2018-07-30       Impact factor: 2.352

Review 9.  Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-11       Impact factor: 3.267

10.  Role of IL28B gene polymorphism and cell-mediated immunity in spontaneous resolution of acute hepatitis C.

Authors:  Enea Spada; Pietro Amoroso; Gloria Taliani; Ornella Zuccaro; Piergiorgio Chiriacò; Patrizia Maio; Giuseppe Maio; Maria Luisa Esposito; Corrado Mariano; Roberto Rinaldi; Pietro Bellissima; Maria Elena Tosti; Paola Del Porto; Ruggiero Francavilla; Vincenzo Mellace; Anna Rosa Garbuglia; Antonella Folgori; Alfonso Mele
Journal:  Clin Infect Dis       Date:  2013-06-19       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.